Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 19-Nov-24 8:13 PM View:  | Longboard Pharmaceuticals, ... (LBPH) | 19-Nov-24 | Option Exercise | 30,554 | $6.00 | $183,324.00 | 171% 17.92K to 48.47K | |
| 16-Oct-24 4:40 PM View: | Longboard Pharmaceuticals, ... (LBPH) | 15-Oct-24 | Option Exercise | 16,667 | $4.35 | $72,501.40 | 93% 17.92K to 34.59K | 4% |
| 16-Oct-24 4:40 PM View: | Longboard Pharmaceuticals, ... (LBPH) | 15-Oct-24 | Planned Private Option Sale | 16,667 | $59.03 | $983,936.00 | (48%) 34.59K to 17.92K | |
| 16-Sep-24 7:36 PM View: | Longboard Pharmaceuticals, ... (LBPH) | 16-Sep-24 | Option Exercise | 16,666 | $4.35 | $72,497.10 | 93% 17.92K to 34.59K | 4% |
| 16-Sep-24 7:36 PM View: | Longboard Pharmaceuticals, ... (LBPH) | 16-Sep-24 | Planned Private Option Sale | 16,666 | $31.64 | $527,318.00 | (48%) 34.59K to 17.92K | |
| 13-Aug-24 6:01 PM View: | Longboard Pharmaceuticals, ... (LBPH) | 12-Aug-24 | Option Exercise | 16,667 | $4.35 | $72,501.40 | 47% 35.84K to 52.51K | |
| 13-Aug-24 6:01 PM View: | Longboard Pharmaceuticals, ... (LBPH) | 12-Aug-24 | Planned Option Sale | 16,567 | $34.73 | $575,332.00 | (32%) 52.51K to 35.94K | |
| 13-Aug-24 6:01 PM View: | Longboard Pharmaceuticals, ... (LBPH) | 12-Aug-24 | Sale (Planned) | 100 | $34.73 | $3,472.76 | (< 1%) 35.94K to 35.84K | |
| 13-Aug-24 6:01 PM View: | Longboard Pharmaceuticals, ... (LBPH) | 25-Jun-24 | Option Sale | 100 | $20.87 | $2,087.00 | (< 1%) 35.94K to 35.84K | |
| 09-Feb-24 4:11 PM View: | Longboard Pharmaceuticals, ... (LBPH) | 08-Feb-24 | Grant | 17,920 | -- | -- | 100% 0 to 17.92K | |
| 13-Aug-24 6:01 PM View: | Longboard Pharmaceuticals, ... (LBPH) | 23-Jan-24 | Purchase | 100 | $24.82 | $2,482.00 | < 1% 35.84K to 35.94K | |
| 24-Dec-15 1:02 PM View: | Axsome Therapeutics, Inc. (AXSM) | 23-Dec-15 | Market Purchase | 1,000 | $9.03 | $9,026.00 | 20% 5.02K to 6.02K | 7% |
| 24-Nov-15 4:26 PM View: | Axsome Therapeutics, Inc. (AXSM) | 24-Nov-15 | Conversion | 5,022 | $5.40 | $27,118.80 | 100% 0 to 5.02K | |
| 13-Sep-11 5:01 PM View: | Avanir Pharmaceuticals (AVNR) | 09-Sep-11 | Market Sale (Planned) | 100,000 | $2.75 | $275,000.00 | (56%) 178.19K to 78.19K | (312%) |
| 07-Jan-11 5:23 PM View: | Avanir Pharmaceuticals (AVNR) | 05-Jan-11 | Market Sale (Planned) | 10,000 | $4.05 | $40,500.00 | (5%) 188.19K to 178.19K | (179%) |
| 15-Dec-10 8:39 PM View: | Avanir Pharmaceuticals (AVNR) | 13-Dec-10 | Payment of Exercise | 1,446 | $3.92 | $5,668.32 | (< 1%) 189.64K to 188.19K | (184%) |
| 08-Dec-10 12:33 PM View: | Avanir Pharmaceuticals (AVNR) | 06-Dec-10 | Market Sale (Planned) | 10,000 | $3.80 | $38,000.00 | (5%) 199.64K to 189.64K | (193%) |
| 03-Dec-10 9:02 PM View: | Avanir Pharmaceuticals (AVNR) | 01-Dec-10 | Grant | 17,500 | -- | -- | 9% 191.84K to 209.34K | |
| 08-Nov-10 9:26 PM View: | Avanir Pharmaceuticals (AVNR) | 05-Nov-10 | Market Sale (Planned) | 10,000 | $4.76 | $47,556.00 | (5%) 209.64K to 199.64K | (134%) |
| 05-Oct-10 8:25 PM View: | Avanir Pharmaceuticals (AVNR) | 05-Oct-10 | Market Sale (Planned) | 10,000 | $3.23 | $32,269.00 | (4%) 249.54K to 239.54K | (245%) |
| 15-Sep-10 6:13 PM View: | Avanir Pharmaceuticals (AVNR) | 13-Sep-10 | Payment of Exercise | 1,447 | $2.70 | $3,906.90 | (< 1%) 250.98K to 249.54K | (312%) |
| 08-Sep-10 9:48 PM View: | Avanir Pharmaceuticals (AVNR) | 07-Sep-10 | Market Sale (Planned) | 10,000 | $2.70 | $27,034.00 | (4%) 260.98K to 250.98K | (312%) |
| 20-Aug-10 7:18 PM View: | Avanir Pharmaceuticals (AVNR) | 18-Aug-10 | Market Sale | 35,000 | $3.08 | $107,664.00 | (12%) 295.98K to 260.98K | (262%) |
| 09-Aug-10 7:01 PM View: | Avanir Pharmaceuticals (AVNR) | 05-Aug-10 | Market Sale (Planned) | 10,000 | $3.28 | $32,800.00 | (3%) 305.98K to 295.98K | (239%) |
| 09-Jul-10 5:34 PM View: | Avanir Pharmaceuticals (AVNR) | 07-Jul-10 | Market Sale (Planned) | 10,000 | $3.02 | $30,203.00 | (3%) 315.98K to 305.98K | (269%) |
| 15-Jun-10 7:32 PM View: | Avanir Pharmaceuticals (AVNR) | 13-Jun-10 | Payment of Exercise | 1,447 | $2.71 | $3,921.37 | (< 1%) 317.43K to 315.98K | (311%) |
| 08-Jun-10 8:21 PM View: | Avanir Pharmaceuticals (AVNR) | 07-Jun-10 | Market Sale (Planned) | 50,000 | $2.38 | $119,115.00 | (14%) 367.43K to 317.43K | (367%) |
| 16-Mar-10 4:11 PM View: | Avanir Pharmaceuticals (AVNR) | 13-Mar-10 | Payment of Exercise | 1,448 | $2.13 | $3,084.24 | (< 1%) 368.88K to 367.43K | (423%) |
| 05-Jan-10 4:44 PM View: | Avanir Pharmaceuticals (AVNR) | 04-Jan-10 | Payment of Exercise | 28,499 | $1.97 | $56,143.00 | (7%) 396.96K to 368.46K | (465%) |
| 15-Dec-09 9:15 PM View: | Avanir Pharmaceuticals (AVNR) | 13-Dec-09 | Payment of Exercise | 1,350 | $1.82 | $2,457.00 | (< 1%) 398.31K to 396.96K | (512%) |
| 15-Sep-09 9:18 PM View: | Avanir Pharmaceuticals (AVNR) | 15-Sep-09 | Market Sale | 2,000 | $2.10 | $4,200.00 | (< 1%) 400.31K to 398.31K | (430%) |
| 15-Sep-09 9:18 PM View: | Avanir Pharmaceuticals (AVNR) | 13-Sep-09 | Payment of Exercise | 1,349 | $2.21 | $2,981.29 | (< 1%) 401.66K to 400.31K | (404%) |
| 15-Sep-09 9:18 PM View: | Avanir Pharmaceuticals (AVNR) | 11-Sep-09 | Market Purchase | 2,000 | $2.18 | $4,360.00 | < 1% 399.66K to 401.66K | 411% |
| 17-Jul-09 7:12 PM View: | Avanir Pharmaceuticals (AVNR) | 15-Jul-09 | Payment of Exercise | 23,425 | $2.13 | $49,895.30 | (6%) 423.08K to 399.66K | (429%) |
| 15-Jun-09 8:44 PM View: | Avanir Pharmaceuticals (AVNR) | 13-Jun-09 | Payment of Exercise | 1,217 | $1.31 | $1,594.27 | (< 1%) 424.3K to 423.08K | (761%) |
| 17-Mar-09 4:57 PM View: | Avanir Pharmaceuticals (AVNR) | 13-Mar-09 | Payment of Exercise | 1,440 | $0.45 | $648.00 | (< 1%) 425.74K to 424.3K | (2459%) |
| 25-Feb-09 3:37 PM View: | Avanir Pharmaceuticals (AVNR) | 23-Feb-09 | Market Purchase | 10,000 | $0.43 | $4,263.00 | 2% 415.74K to 425.74K | 2602% |
| 17-Sep-08 1:48 PM View: | Avanir Pharmaceuticals (AVNR) | 15-Sep-08 | Payment of Exercise | 1,217 | $0.83 | $1,010.11 | (< 1%) 416.95K to 415.74K | (1288%) |
| 16-Jun-08 7:37 PM View: | Avanir Pharmaceuticals (AVNR) | 13-Jun-08 | Payment of Exercise | 1,217 | $1.11 | $1,350.87 | (< 1%) 418.17K to 416.95K | (938%) |
| 17-Mar-08 6:29 PM View: | Avanir Pharmaceuticals (AVNR) | 13-Mar-08 | Payment of Exercise | 1,440 | $1.10 | $1,584.00 | (< 1%) 419.61K to 418.17K | (947%) |
| 22-Jan-08 7:41 PM View: | Avanir Pharmaceuticals (AVNR) | 17-Jan-08 | Payment of Exercise | 4,983 | $1.13 | $5,630.79 | (1%) 424.6K to 419.61K | (919%) |
| 17-Dec-07 8:45 PM View: | Avanir Pharmaceuticals (AVNR) | 13-Dec-07 | Payment of Exercise Duplicate | 5,148 | $1.66 | $8,545.68 | (1%) 417.24K to 412.1K | (594%) |
| 06-Dec-07 8:04 PM View: | Avanir Pharmaceuticals (AVNR) | 04-Dec-07 | Grant | 107,143 | -- | -- | 35% 310.1K to 417.24K | |
| 22-Mar-07 7:54 PM View: | Avanir Pharmaceuticals (AVNR) | 21-Mar-07 | Grant | 250,000 | -- | -- | 407% 61.35K to 311.35K | |
| 14-Dec-06 9:11 PM View: | Avanir Pharmaceuticals (AVNR) | 13-Dec-06 | Grant | 57,600 | -- | -- | 1536% 3.75K to 61.35K | |
| 26-May-06 2:41 PM View: | Avanir Pharmaceuticals (AVNR) | 26-May-06 | Market Purchase | 2,000 | $10.14 | $20,280.00 | 160% 1.25K to 3.25K | 14% |
| 26-May-06 2:41 PM View: | Avanir Pharmaceuticals (AVNR) | 26-May-06 | Market Purchase | 500 | $9.90 | $4,949.50 | 15% 3.25K to 3.75K | 16% |
| 22-Jan-08 7:41 PM View: | Avanir Pharmaceuticals (AVNR) | 08-May-06 | Option Exercise | 12,500 | $0.04 | $500.00 | 3% 412.1K to 424.6K |